drugset / Trial / NCT03199664

Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo

NCT03199664 ↗

Phase 4 Unknown 100 enrolled South Valley University
RandomizedParallel-groupOpen-labelTreatment

Summary

The study will compare the effectiveness of combined treatment with NB-UVB and tacrolimus versus NB-UVB alone . Patients will be treated for 6 months and followed up after 3 months .All types of vitiligo will be included except universal vitiligo.

Timeline

Start
2017-09-01
Primary completion
2018-09-01
Completion
2018-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.03 % Topical

Indications